BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 15865093)

  • 1. Clinical impact of metastatic lymph node ratio in advanced gastric cancer.
    Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
    Anticancer Res; 2005; 25(2B):1369-75. PubMed ID: 15865093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
    Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of positive lymph node ratio in gastric carcinoma.
    Celen O; Yildirim E; Berberoglu U
    J Surg Oncol; 2007 Aug; 96(2):95-101. PubMed ID: 17443727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer.
    Saito H; Fukumoto Y; Osaki T; Yamada Y; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2008 Feb; 97(2):132-5. PubMed ID: 17979134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic lymph node ratio as a prognostic factor in gastric cancer.
    Rodríguez Santiago JM; Muñoz E; Martí M; Quintana S; Veloso E; Marco C
    Eur J Surg Oncol; 2005 Feb; 31(1):59-66. PubMed ID: 15642427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series.
    Marchet A; Mocellin S; Ambrosi A; de Manzoni G; Di Leo A; Marrelli D; Roviello F; Morgagni P; Saragoni L; Natalini G; De Santis F; Baiocchi L; Coniglio A; Nitti D;
    Eur J Surg Oncol; 2008 Feb; 34(2):159-65. PubMed ID: 17566691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of para-aortic lymph node dissection in advanced gastric cancer.
    Kunisaki C; Shimada H; Yamaoka H; Wakasugi J; Takahashi M; Akiyama H; Nomura M; Moriwaki Y
    Hepatogastroenterology; 1999; 46(28):2635-42. PubMed ID: 10522056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer?
    Bilici A; Ustaalioglu BB; Gumus M; Seker M; Yilmaz B; Kefeli U; Yildirim E; Sonmez B; Salepci T; Kement M; Mayadagli A
    Onkologie; 2010; 33(3):101-5. PubMed ID: 20215800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of metastatic lymph node ratio in T3 gastric cancer.
    Hyung WJ; Noh SH; Yoo CH; Huh JH; Shin DW; Lah KH; Lee JH; Choi SH; Min JS
    World J Surg; 2002 Mar; 26(3):323-9. PubMed ID: 11865369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes.
    Xu DZ; Geng QR; Long ZJ; Zhan YQ; Li W; Zhou ZW; Chen YB; Sun XW; Chen G; Liu Q
    Ann Surg Oncol; 2009 Feb; 16(2):319-26. PubMed ID: 19050970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node metastases in gastric cancer: correlation between new and old UICC TNM classification.
    Omejc M; Juvan R; Jelenc F; Repse S
    Int Surg; 2001; 86(1):14-9. PubMed ID: 11890334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage in gastric carcinoma.
    Hepatogastroenterology; ; . PubMed ID: 10626202
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.